Kuzari Group

ONA offers a range of handcrafted premium camera bags and accessories. It was launched in 2010 and is based in New York, United States.

Precipio Diagnostics is a cancer diagnostics company based in New Haven, Connecticut, specializing in clinical diagnostic services for hematopoietic cancers. The company offers advanced diagnostic products, including the HemeScreen panel for genetic mutation testing and the IV-Cell media, which enhances the accuracy of laboratory results. Precipio serves a diverse clientele, including oncologists, hospitals, reference laboratories, and pharmaceutical companies. In its commitment to improving cancer care, the company collaborates with prominent academic institutions such as the Yale School of Medicine and Dana-Farber Cancer Institute, fostering connections between physicians and leading pathologists. With laboratories in New Haven and Omaha, Precipio aims to reduce instances of cancer misdiagnoses and provide essential diagnostics to oncologists across the United States.

New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that leverage currently marketed drugs and generally recognized as safe (GRAS) active pharmaceutical ingredients for therapeutic applications with substantial market potential. The company is advancing a product pipeline that features innovative, oral, controlled-release technologies, enhancing dosing accuracy, safety, efficacy, and patient convenience. NHP's research is supported by intellectual property licensed from Yale University, allowing for the development of new therapeutic indications using established compounds.